微管稳定剂和前列腺癌之间的交叉连接
1Department of Chemistry and Biochemistry, California State University, Fresno, CA 93740, USA.
Cancers
|July 14, 2023
概括
微管稳定剂 (MSAs) 通过破坏细胞分裂和抑制雄激素受体信号传递,提供针对前列腺癌的双重机制. 这些药物显示为割敏感和割抗性前列腺癌的有效治疗方法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
- 海洋天然产品 化学 化学
背景情况:
- 来自自然来源的微管稳定剂 (MSA) 在癌症治疗中至关重要.
- 多塞塔克塞尔和卡巴西塔克塞尔是唯一获得批准的药物,可以改善割抵抗性前列腺癌 (CRPC) 的存活率.
- MSAs表现出双重的作用机制,超出了线粒体的停止,影响雄激素受体 (AR) 信号传递.
研究的目的:
- 审查各种MSAs的抗前列腺癌疗效.
- 阐明MSA在前列腺癌中的双重作用机制.
- 探索MSAs作为前列腺癌治疗选择的潜力.
主要方法:
- 对前列腺癌中MSAs的临床前和临床研究的综述.
- 分析MSAs的分子机制,包括线粒体停止和AR路径干扰.
- 在前列腺癌患者中评估MSA的临床使用和结果.
主要成果:
- MSA在AR阳性和AR无前列腺癌细胞中都表现出有效性.
- 抑制AR核积累是AR驱动CRPC中MSA的一个关键机制.
- 可以单独或组合使用MSA,以增强治疗效果.
结论:
- MSA 具有对治疗前列腺癌至关重要的双重机制.
- 这些药物代表了对割敏感和割抵抗性前列腺癌的有前途的治疗策略.
- 对MSA的进一步调查可能会导致改善所有形式的前列腺癌的治疗选择.
更多相关视频
相关概念视频
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Destabilization of Microtubules
2.8K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.8K
Microtubule Associated Proteins (MAPs)
4.4K
Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
4.4K
Microtubule Instability
5.2K
Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
5.2K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


